{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:33:07Z","timestamp":1741753987384,"version":"3.38.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"3-4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,27]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Glycemic monitoring via Hemoglobin A1(HbA1c) proves to be inaccurate when a patient is diagnosed with a hemoglobinopathy\/erythrocyte disorder. Moreover, any acute changes of glycemic intake within 6 weeks of blood sampling have been noted to impart a greater effect on HbA1c than the remaining days of the supposed overall 3-to-4-month average of glycemic control. Fructosamine, an alternative to HbA1c, allows physicians to analyze glycemic control in the presence of an underlying hemoglobinopathy\/erythrocyte disorder. Fructosamine analyzes glycemic control over a two-to-three week period, compared to a 3-to-4-month period with HbA1c. Studies indicate that fructosamine is significantly correlated with HbA1c in various population types. Given the increased likelihood of hemaglobinopathies\/erythrocyte disorders in the veteran population accompanied by the the necessity for tighter glycemic evaluation, fructosamine offers an assay for physician when analyzing glycemic control in veterans. The aim of our study was to evaluate the correlation of HbA1c and fructosamine in the veteran community. We hypothesize that fructosamine is significantly correlated with HbA1c in the veteran community and therefore can be used as an alternative assay in the Veterans Affairs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>Following institutional review board review and exemption, a retrospective chart review was conducted at the Northport Veterans Affairs between the dates of December 2007 and December 2018. Inclusion criteria consisted of veterans above the age of 18 years with a HbA1c and fructosamine assay drawn from the same blood sample. Exclusion criteria consisted of veterans with an underlying hemoglobinopathy, erythrocyte disorder, or serum protein altering pathology. Linear regression analysis was conducted between HbA1c and fructosamine values. Linear regression equation, correlation coefficient, and coefficient of variance were reported. A paired t-test was conducted between assay HbA1c and predicted HbA1c from the determined regression equation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 156 veterans were included in this study. A correlation coefficient and coefficient of variance of 0.75 and 0.56 were calculated from regression analysis (P\u2009&amp;lt;\u20090.05). A regression equation of the following was determined: HbA1c{%}\u2009=\u20090.0154*Fructosamine (mmol\/L)+\u20093.121. Paired t-test of assay HbA1c (M\u2009=\u20098.17, standard deviation\u2009=\u20091.64) and predicted HbA1c (M\u2009=\u20098.21, standard deviation\u2009=\u20091.53) returned without significance for difference of paired values.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Given that both correlation coefficient and coefficient of variance were considered significantly strong and the paired t-test indicated no significant difference between assay HbA1c and predicted HbA1c, fructosamine can be considered as an alternative assessment of glycemic control compared to HbA1c in the veteran community. We advise physicians at the Veterans Affairs to use fructosamine as an assessment of glycemic control when a veteran is diagnosed with an underlying hemoglobinopathy\/erythrocyte disorder or requires stringent analysis of glycemic control. Yet, at this point of time, fructosamine does not have the necessary data to indicate complete replacement of HbA1c with fructosamine.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/milmed\/usad434","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T20:21:27Z","timestamp":1734121287000},"page":"e724-e727","source":"Crossref","is-referenced-by-count":0,"title":["Fructosamine as an Indicator for\u00a0Glycemic Control in\u00a0the Veteran Community"],"prefix":"10.1093","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5064-9072","authenticated-orcid":false,"given":"Wendy","family":"Young","sequence":"first","affiliation":[{"name":"Department of Podiatric Medicine and Surgery, Northport Veterans Affairs , Northport, NY 11768,","place":["USA"]},{"name":"Department\u00a0of Surgery, Podiatric Surgery, Stony Brook University Hospital , Stony Brook, NY 11794,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Nunez","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Northport Veterans Affairs , Northport, NY 11768,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Fleischman","sequence":"additional","affiliation":[{"name":"Department\u00a0of Surgery, Podiatric Surgery, Stony Brook University Hospital , Stony Brook, NY 11794,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Commodore","sequence":"additional","affiliation":[{"name":"Department\u00a0of Surgery, Podiatric Surgery, Stony Brook University Hospital , Stony Brook, NY 11794,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"issue":"(5 Suppl 1)","key":"2025031111130711500_R1","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.3949\/ccjm.83.s1.02","article-title":"The role of hemoglobin A1c in the assessment of diabetes and cardiovascular disease","volume":"83","author":"Sandler","year":"2016","journal-title":"CCJM"},{"issue":"6","key":"2025031111130711500_R2","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1172\/JCI108436","article-title":"The biosynthesis of\u00a0human hemoglobin A1c. Slow glycosylation of\u00a0hemoglobin in\u00a0vivo","volume":"57","author":"Bunn","year":"1976","journal-title":"J Clin Invest"},{"issue":"4","key":"2025031111130711500_R3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.20452\/pamw.913","article-title":"Difficulties in\u00a0interpreting HbA(1c) results","volume":"120","author":"Homa","year":"2010","journal-title":"Pol Arch Med Wewn"},{"issue":"2","key":"2025031111130711500_R4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11606-013-2595-x","article-title":"Pitfalls in\u00a0hemoglobin A1c measurement: when results may be misleading","volume":"29","author":"Radin","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"7","key":"2025031111130711500_R5","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1001\/archinte.1982.00340200140026","article-title":"Spurious elevations in\u00a0glycosylated hemoglobin (HbA1) secondary to hypertriglyceridemia","volume":"142","author":"Falko","year":"1982","journal-title":"Arch Intern Med"},{"issue":"2","key":"2025031111130711500_R6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/1932296814567227","article-title":"Advantages and\u00a0pitfalls of\u00a0fructosamine and\u00a0glycated albumin in\u00a0the diagnosis and treatment of\u00a0diabetes","volume":"9","author":"Danese","year":"2015","journal-title":"J Diabetes Sci Technol"},{"issue":"12","key":"2025031111130711500_R7","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1093\/clinchem\/33.12.2153","article-title":"Fructosamine: structure, analysis, and\u00a0clinical usefulness","volume":"33","author":"Armbruster","year":"1987","journal-title":"Clin Chem"},{"issue":"(8)","key":"2025031111130711500_R8","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.2337\/dc15-2727","article-title":"Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions","volume":"39","author":"Welsh","journal-title":"Diabetes Care"},{"issue":"(12)","key":"2025031111130711500_R9","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1016\/j.bbagen.2013.04.024","article-title":"Clinical, pathophysiological and structure\/function consequences of modification of albumin by Amadori-glucose adducts","volume":"1830","author":"Cohen","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subjects"},{"issue":"6","key":"2025031111130711500_R10","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1177\/193229680800200620","article-title":"A review of\u00a0glycated albumin as an intermediate glycation index for\u00a0controlling diabetes","volume":"2","author":"Roohk","year":"2008","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"2025031111130711500_R11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1373\/clinchem.2010.144949","article-title":"Progression of\u00a0nephropathy in\u00a0type 2 diabetes: the glycation gap is a significant predictor after adjustment for\u00a0glycohemoglobin (Hb A1c)","volume":"57","author":"Rodr\u00edguez-Segade","year":"2011","journal-title":"Clin Chem"},{"issue":"7","key":"2025031111130711500_R12","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.2337\/db07-0028","article-title":"The hemoglobin glycation index is not an independent predictor of\u00a0the risk of\u00a0microvascular complications in\u00a0the Diabetes Control and\u00a0Complications Trial","volume":"56","author":"Lachin","year":"2007","journal-title":"Diabetes"},{"issue":"4","key":"2025031111130711500_R13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jdiacomp.2005.01.004","article-title":"A comparison of\u00a0the glycosylation gap and\u00a0hemoglobin glycation index in\u00a0patients with diabetes","volume":"19","author":"Chalew","year":"2005","journal-title":"J Diabetes Complications"},{"issue":"8","key":"2025031111130711500_R14","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2337\/diacare.27.8.1859","article-title":"Cole TG, Nowatzke W, Houghton S, Ammirati E, Gautille T, Sarno M: Circulating 1,5-Anhydroglucitol Levels in Adult Patients With Diabetes Reflect Longitudinal Changes of Glycemia","volume":"27","author":"Gill","year":"2004","journal-title":"Diabetes Care"},{"key":"2025031111130711500_R15","doi-asserted-by":"publisher","DOI":"10.5888\/pcd14.170230","article-title":"Prevalence of\u00a0and trends in\u00a0diabetes among veterans, United States, 2005-2014","volume":"14","author":"Liu","year":"2017","journal-title":"Prev Chronic Dis"},{"issue":"7","key":"2025031111130711500_R16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3324\/haematol.2014.109967","article-title":"Anemia in\u00a0the elderly: clinical implications and\u00a0new therapeutic concepts","volume":"99","author":"Stauder","year":"2014","journal-title":"Haematologica"},{"issue":"11","key":"2025031111130711500_R17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166635","article-title":"The prevalence of\u00a0anemia and\u00a0moderate-severe anemia in\u00a0the US population (NHANES 2003-2012)","volume":"11","author":"Le","year":"2016","journal-title":"PLoS One"},{"issue":"(4)","key":"2025031111130711500_R18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.14740\/jh182w","article-title":"Anemia in the Elderly Population","volume":"3","author":"Bianchi","journal-title":"J Hematol"},{"issue":"1","key":"2025031111130711500_R19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2337\/diacare.26.1.163","article-title":"Discordance between HbA1c and\u00a0fructosamine: evidence for\u00a0a glycosylation gap and\u00a0its relation to diabetic nephropathy","volume":"26","author":"Cohen","year":"2003","journal-title":"Diabetes Care"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/190\/3-4\/e724\/61149131\/usad434.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/190\/3-4\/e724\/61149131\/usad434.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T11:13:23Z","timestamp":1741691603000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/190\/3-4\/e724\/7923217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":19,"journal-issue":{"issue":"3-4","published-online":{"date-parts":[[2024,12,13]]},"published-print":{"date-parts":[[2025,2,27]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usad434","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"type":"print","value":"0026-4075"},{"type":"electronic","value":"1930-613X"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,12,13]]}}}